(NewsNation) — Bad news for the tooth fairy: Humans may be one step closer to regrowing their teeth with the help of a new drug from Japanese researchers.
The intravenous treatment suppresses uterine sensitization-associated gene-1 (USAG-1) protein, the antibody which prevents tooth regrowth.
Scientists at Kyoto University Hospital will conduct the first human trial of the drug from September 2024 to August 2025. In tests on ferrets and mice, the drug worked with no notable side effects, Popular Mechanics reported.
The drug will be used on 30 men between 30-64 who are missing at least one molar. From there, researchers will expand the study to those with partial edentulism, or those missing one to five permanent teeth.
“We want to do something to help those who are suffering from tooth loss or absence,” said lead researcher Katsu Takahashi, head of dentistry and oral surgery at Kitano Hospital told NewAtlas. While there has been no treatment to date providing a permanent cure, we feel that people’s expectations for tooth growth are high.”
If the trial is effective, the medicine could be commercially available as soon as 2030.
Click this link for the original source of this article.
Author: Anna Kutz
This content is courtesy of, and owned and copyrighted by, https://www.newsnationnow.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.